References
Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, et al. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993;13:295–309.
Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, et al. Rapid detection of Parkinson’s disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse 1998;29:128–41.
Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, et al. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. J Nucl Med 1996;37:1129–33.
Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL. Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism. Nucl Med Commun 1994;15:806–13.
Ichise M, Ballinger JR, Golan H, Vines D, Luong A, Tsai S, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med 1996;37:513–20.
Madsen MT. Recent advances in SPECT imaging. J Nucl Med 2007;48:661–73.
Wagenaar DJ, Kapusta M, Li J, Patt BE. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging. Technol Cancer Res Treat 2006;5:343–50.
Crespo C, Gallego J, Cot A, Falcón C, Bullich S, Pareto D, et al. Quantification of dopaminergic neurotransmission SPECT studies with (123)I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation. Eur J Nucl Med Mol Imaging. 2008;in press. DOI 10.1007/s00259-007-0711-z.
Zaidi H, Montandon M-L, Meikle S. Strategies for attenuation compensation in neurological PET studies. Neuroimage 2007;34:518–41.
El Fakhri G, Kijewski MF, Albert MS, Johnson KA, Moore SC. Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer’s disease. J Nucl Med 2004;45:2026–31.
Zaidi H, Koral KF. Scatter modelling and compensation in emission tomography. Eur J Nucl Med Mol Imaging 2004;31:761–82.
Koch W, Mustafa M, Zach C, Tatsch K. Influence of movement on FP-CIT SPECT quantification: a Monte Carlo based simulation. Nucl Med Commun 2007;28:603–14.
Shao L, Billings J, Pfeiffer N, Kung HF. Concentration recovery for SPECT CNS dopamine-receptor studies for monkeys. Med Phys 1994;21:675–81.
Soret M, Koulibaly PM, Darcourt J, Hapdey S, Buvat I. Quantitative accuracy of dopaminergic neurotransmission imaging with 123I SPECT. J Nucl Med 2003;44:1184–93.
Cherry S, Sorenson JA, Phelps ME. Physics in nuclear medicine. 3rd ed. Philadelphia: Saunders; 2004.
Rowe RK, Aarsvold JN, Barrett HH, Chen JC, Klein WP, Moore BA, et al. A stationary hemispherical SPECT imager for three-dimensional brain imaging. J Nucl Med 1993;34:474–80.
Genna S, Smith AP. The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci 1988;35:654–8.
El Fakhri G, Ouyang J, Zimmerman RE, Fischman AJ, Kijewski MF. Performance of a novel collimator for high-sensitivity brain SPECT. Med Phys 2006;33:209–15.
Rogers WL, Clinthorne NH, Shao L, Chiao P, Ding Y, Stamos JA, et al. SPRINT II: a second generation single photon ring tomograph. IEEE Trans Med Imaging 1988;7:291–7.
Farncombe T, Celler A, Noll D, Maight J, Harrop R. Dynamic SPECT imaging using a single camera rotation (dSPECT). IEEE Trans Nucl Sci 1999;46:1055–61.
Wong WH, Li H, Uribe J, Baghaei H, Wang Y, Yokoyama S. Feasibility of a high-speed gamma-camera design using the high-yield-pileup-event-recovery method. J Nucl Med 2001;42:624–32.
Ljungberg M, Strand S-E, King MA. Monte Carlo calculations in nuclear medicine: applications in diagnostic imaging. Bristol: IOP Publishing; 1998.
Zaidi H. Relevance of accurate Monte Carlo modeling in nuclear medical imaging. Med Phys 1999;26:574–608.
Dewaraja YK, Ljungberg M, Koral KF. Monte Carlo evaluation of object shape effects in iodine-131 SPET tumor activity quantification. Eur J Nucl Med 2001;28:900–6.
Floyd CE, Jaszczak RJ, Greer KL, Coleman RE. Inverse Monte Carlo as a unified reconstruction algorithm for ECT. J Nucl Med 1986;27:1577–85.
Beekman FJ, de Jong HW, van Geloven S. Efficient fully 3-D iterative SPECT reconstruction with Monte Carlo-based scatter compensation. IEEE Trans Med Imag 2002;21:867–77.
Ouyang J, Fakhri GE, Moore SC. Fast Monte Carlo based joint iterative reconstruction for simultaneous [sup 99m]Tc/[sup 123]I SPECT imaging. Med Phys 2007;34:3263–72.
Wilson DW, Tsui BMW, Barrett HH. Noise properties of the EM algorithm. II. Monte Carlo simulations. Phys Med Biol 1994;39:847–71.
Zaidi H, Xu XG. Computational anthropomorphic models of the human anatomy: the path to realistic Monte Carlo modeling in medical imaging. Annu Rev Biomed Eng 2007;9:471–500.
Koch W, Hamann C, Radau PE, Tatsch K. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? Eur J Nucl Med Mol Imaging 2007;34:1265–73.
Tossici-Bolt L, Hoffmann SMA, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nuc Med Mol Imaging 2006;33:1491–9.
El Fakhri G, Moore SC, Maksud P, Aurengo A, Kijewski MF. Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT. J Nucl Med 2001;42:300–8.
Du Y, Tsui BMW, Frey EC. Model-based compensation for quantitative 123I brain SPECT imaging. Phys Med Biol 2006;51:1269–82.
Vanzi E, De Cristofaro M, Ramat S, Sotgia B, Mascalchi M, Formiconi A. A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements. Eur J Nuc Med Mol Imaging 2007;34:1480–9.
Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46:1109–18.
Author information
Authors and Affiliations
Corresponding author
Additional information
This Editorial Commentary refers to the article doi:10.1007/s00259-007-0711-z.
Rights and permissions
About this article
Cite this article
Zaidi, H., El Fakhri, G. Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?. Eur J Nucl Med Mol Imaging 35, 1330–1333 (2008). https://doi.org/10.1007/s00259-008-0842-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-008-0842-x